CLDX   $30.995  3.21% Market Open

Celldex Therapeutics, Inc.
Total Cash 802.32M
totalCashPerShare 12.104
EBITDA -160.19M
Total Debt 2.38M
quickRatio 29.064
currentRatio 29.358
Total Revenue 8.30M
debtToEquity 0.293
Revenue/Share 0.148
ROA -0.17828
ROE -0.27532
grossProfits
freeCashflow -56.81M
operatingCashflow -121.49M
earningsGrowth
revenueGrowth 8.321
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -18.54163
profitMargins 0.0
enterpriseValue 1.03B
forwardPE -9.21
floatShares 66.10M
sharesOutstanding 66.29M
sharesShort 8.40M
sharesShortPriorMonth 8.41M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.09%
Short Ratio help_outline 5.40%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 12.276
Price To Book help_outline 2.25
earningsQuarterlyGrowth
netIncomeToCommon -150.22M
trailingEps -2.75%
forwardEps -3.10%
enterpriseToEbitda -6.44
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.67 3Q 2024
institutionsCount 265
lastUpdated Nov. 7, 2024, 9:23 a.m.